Elezanumab (Anti-RGMA)
Product Specifications
CAS Number
1791416-49-3
Synonyms
ABT-555, AE12-1Y-QL
Target
TGF-beta/Smad
Applications
TGF-beta/Smad
Additionnal Information
Elezanumab (Anti-RGMA) is a human monoclonal antibody that selectively targets repulsive guidance molecule A (RGMa) . Elezanumab potently inhibited RGMa mediated BMP signalling via the SMAD1/5/8 pathway with IC50 of 97 pM. MW: 146.44 kD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC681429-500 1x 500 µL
E-Cadherin / CD324 (Intercellular Junction Marker) (4A2), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401073-500 1x 500 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400676-100 1x 100 µL
MUC18 / Mucin 18 / CD146 (OJ79c), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471104-100 1x 100 µL
PAX2 (Renal Cell & Ovarian Carcinoma Marker) (PAX2/1104), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401593-500 1x 500 µL
Aurora B (Proliferation Marker) (AURKB/1593), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC742078-100 1x 100 µL
TCL1 (T-Cell Marker) (TCL1/2078), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details